1–10 of 13 results for Zone
Ellipsoid Zone Integrity Preservation and Characterization of Ellipsoid Zone Integrity Features in the GATHER 1 Phase 2/3 Study
Justis P. Ehlers, MD, FASRS
Annual Meeting Talks
2023
Evaluation of EZ At-Risk Burden in Automatic Detection of Hydroxychloroquine Retinopathy
Katherine E Talcott, MD
Comparison of Complete vs Incomplete Closure of Zone 3 Scleral Lacerations
Pedro S Tetelbom, MD
Use of Ellipsoid Zone Analysis As an Efficacy Endpoint in Clinical Trials for Geographic Atrophy
Peter K. Kaiser, MD FASRS
Protective Effects of ANX007 on Central Macular Ellipsoid Zone (EZ) and Retinal Pigment Epithelium (RPE) and Association with Visual Acuity in the Phase 2 ARCHER GA Study
Glenn J. Jaffe, MD
2024
Post Hoc Analyses of Responder Status in Phase 3 Studies of Ciliary Neurotrophic Factor-Producing Revakinagene Taroretcel in People With Macular Telangiectasia Type 2
John A. Wells, MD, FACS
Baseline Ellipsoid Zone Integrity Features as Predictors of Geographic Atrophy Growth Rate in the Phase 3 GATHER Clinical Trials
Post Hoc Analyses of Responder Status in Phase 3 Studies of Ciliary Neurotrophic Factor–Producing Revakinagene Taroretcel in People With Macular Telangiectasia Type 2
Updates from the Field
Modeling Zone as a Proxy for Absolute Avascular Retina Area and Retinopathy of Prematurity Risk
Darius M. Moshfeghi, MD, FASRS
2022
Foveal Avascular Zone Analysis in Eyes Following Retinal Detachment Repair: A Comparison Between Eyes With Retinal Displacement Versus Without Displacement
Carolina Lampert Monte Francisconi, MD
On Demand Cases, Courses, and Papers
2020